Echometrix, a Madison-based developer of proprietary musculoskeletal ultrasound technology, was awarded a patent on its ultrasound technology for the dynamic functional analysis of injured and healing tissues, the company announced today.

“The issuance of this patent will have broad-reaching effects in clinical and veterinary medicine, as well as in research into new musculoskeletal treatments,” CEO Jeff Dalsin said in a statement. “It is an important step in translating the foundational patents that the company licenses from the Wisconsin Alumni Research Foundation into a commercializable product.”

The patent is the first for Echometrix.